FDA Approved: LEVETIRACETAM ER — Supplemental Application (Westminster Pharmaceuticals, LLC)

View source ↗

Summary

The FDA approved Westminster Pharmaceuticals' supplemental application to authorize the levetiracetam extended-release formulation (LEVETIRACETAM ER).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Generalized Tonic-clonic Seizures
• Myoclonic Seizures
• Partial-onset Seizures

Drugs mentioned

• LEVETIRACETAM ER (LEVETIRACETAM)

Snippet

SUPPL AP for LEVETIRACETAM ER (LEVETIRACETAM)